Cancer Nanovaccine Game

banner of Nano Vaccine game logo


The Cancer Nanovaccine Game is an educational tool developed by the Center for Immunotherapeutic Transport Oncophysics of the National Cancer Institute at the Houston Methodist Research Institute. The educational game has five levels illustrating the assembly of a cancer nanovaccine (level 1), the uptake of the nanovaccine by dendritic cells (level 2), dendritic cell-mediated activation of T cells in the lymph nodes (level 3), T cell transport from the lymphatic system to the tumor (level 4), and T cell-mediated killing of cancer cells (level 5). This game is intended for educational outreach to teach the principles and science behind nanovaccine research conducted at Houston Methodist. Questions should be addressed to: Aaron Santos.

Download the game


REQUIREMENTS
 
The Nano Vaccine Game was created using the Godot Engine version 3.2. The recommended hardware is Windows 7 or newer, macOS 10.10 or newer, Linux  (64-bit or 32-bit x86) Hardware supporting OpenGL 3.3 Core Profile.
  
INSTALLATION

  1. Download NanoVax_Game.zip from the provided DropBox link and extract it to an empty directory of your choosing.
  2. Download the latest version of the Godot game engine, which can be found here: https://godotengine.org/download/
  3. Open the Godot executable file downloaded in step #2
  4. Select "Import" from the Godot menu. Navigate to the directory you selected in step #1, and then open the folder "2 - Prod". Open the file named project.godot. This will open the source code for the Nano Vaccine Game within the Godot game engine. 



CONCEPTUALIZATION/DEVELOPMENT: DNP123, Aaron Santos, & Joy Wolfram

SCIENTIFIC GUIDANCE: Qing Shi, Louis Hinkle

PATIENT ADVOCACY: Anne Meyn AND Ashley Dedmon

GRAPHIC/GAME DESIGN: Aaron Santos, Oscar Wacker-Lackaff, AND Mohamed Hassan

MUSIC: Royalty Free Music from Bensound

ADMINISTRATIVE SUPPORT: Maricela Ramirez, Christy Le, Taliya Perera

SPECIAL THANKS: Tarek R. Fadel, PhD, Brody P. Viveiros, and Zachary C. Viveiros
Research News
doctor holding a tablet with a chest scan on it's screen
Personalized Treatment Strategies for Lung Cancer
Houston Methodist researchers identified a novel and innovative marker to guide Immune Checkpoint Inhibitor Therapy for Lung Cancer.
woman sitting on an examination table in a doctor's office
Trailblazing New Perspectives: Treating Gynecological Cancers
The goal of this new study was to evaluate the feasibility of a phase three, multi-center randomized clinical trial comparing the efficacy of minimally invasive surgery with that of the traditional open method approach (laparotomy) in treating epithelial ovarian cancer.
arm in blood pressure testing machine
Getting to the Heart of Hypertension Disparities
Researchers address social risk factors for high blood pressure through a national study.
Evolving Treatment Beyond Pharmaceuticals
First-of-its-Kind Study Explores Novel Prescription Digital Therapeutic
An Unusual Presentation of Glioblastoma
Andrew Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, recently published one of the first-ever reported cases of progressive vision loss as the presenting manifestation of recurrent GBM with secondary LMS to the optic chiasm.
Engaging T cell Exhaustion for Solid Tumor Immunotherapies
Houston Methodist researchers investigated T cell exhaustion in murine models of prostate cancer and melanoma to explore possible advancements in immunotherapies for solid tumors.
Fighting a Deadly Duo
Investigating therapeutics to fight deadly TB/HIV coinfections.
Houston Methodist, Rice University launch groundbreaking Digital Health Institute
This initiative builds on ongoing collaborations between Houston Methodist and Rice University to transform the future of health care.
Stage I Nodal Marginal Zone Lymphoma Treatment Landscape
Houston Methodist researchers compared systemic therapy and radiation therapy in Stage I Nodal Marginal Zone Lymphoma Patients
2024 Digital Health Workshop Seed Fund Award Winners Announced
Houston Methodist researchers and their collaborators from Rice University have been awarded grants from the 2024 PATHS-UP Digital Health Workshop.
Pilot Study Offers Insight Into Alzheimer’s Research Participants Perceptions and Self-Efficacy
In a Houston Methodist study, Alzheimer’s disease research participants showed a high interest in genetic testing and provided valuable insights that can improve how test results are disclosed.
Breast Cancer Cells
Nanomedicine Makes Big Strides in the Fight Against Breast Cancer
Researchers deliver immunotherapy directly into triple-negative breast cancer tumors with nanofluidic implants, achieving tunable and sustained dosing of immunotherapeutics with high anti-tumor activity.
headshot of Constance Mobley smiling
Liver Failure Avengers Houston Methodist Researchers First in World
Under the leadership of Constance Mobley, MD, PhD, FACS, researchers have successfully performed a first-in-human miniature liver hepatocyte transplant to change a patient’s lymph nodes into ectopic miniature livers.
Predicting the Future of Cancer Treatment

Houston Methodist faculty developed a multiscale mechanistic model to further investigate the role of miR-155 in non-small cell lung cancer and predict clinical efficacy based on preclinical data.

Taking a Closer Look at West Nile Neuroimaging

A case report reviewing West Nile neuroinvasive disease imaging characteristics and the differential diagnosis of acute leukoencephalopathy highlights the usefulness of neuroimaging in WNND diagnosis in the absence of CSF markers.

Ending Organ Transplant Rejection

Studies at Houston Methodist suggest a novel strategy that may potentially eliminate or diminish transplant rejection, autoimmune diseases, and the need for immunosuppressive drugs

Location, Location, Location is Key to Pancreatic Cancer Prognosis

Molecular alterations found in pancreatic ductal adenocarcinoma samples may have potential therapeutic implications

Explore the following:

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now